Last $23.29 USD
Change Today +0.63 / 2.78%
Volume 432.7K
ANAC On Other Exchanges
Symbol
Exchange
NASDAQ GM
Berlin
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - ANACOR PHARMACEUTICALS INC (ANAC)

Anacor Pharmaceuticals, Inc. to Report Q2, 2014 on Aug 07, 2014
CapIQ 08/07/2014 4:00 AM ET
Anacor Pharmaceuticals, Inc. to Report Q1, 2014 on May 07, 2014
CapIQ 08/07/2014 4:00 AM ET
Anacor Pharmaceuticals, Inc. to Report Q4, 2013 on Mar 13, 2014
CapIQ 08/07/2014 4:00 AM ET

2013 revenues at Anacor Pharmaceuticals, Inc. totaled $17.3M USD, while annual losses equaled $1.37 per share.

Quarterly Earnings & Estimates - ANACOR PHARMACEUTICALS INC (ANAC)

Actuals vs. Estimates for ANACOR PHARMACEUTICALS INC ANAC

Anacor Pharmaceuticals, Inc.'s Quarterly Earnings

Anacor Pharmaceuticals, Inc. reported 2nd quarter 2014 losses of $0.58 per share on 08/9/2014.

Annual Earnings & Estimates - ANACOR PHARMACEUTICALS INC (ANAC)

Actuals vs. Estimates for ANACOR PHARMACEUTICALS INC ANAC

Anacor Pharmaceuticals, Inc.'s Annual Earnings

Anacor Pharmaceuticals, Inc. reported annual 2013 losses of $1.37 per share on 03/15/2014.

Quarterly Revenues - ANACOR PHARMACEUTICALS INC (ANAC)

Actuals vs. Estimates for ANACOR PHARMACEUTICALS INC ANAC

Anacor Pharmaceuticals, Inc.'s Quarterly Revenues

Anacor Pharmaceuticals, Inc. had 2nd quarter 2014 revenues of $2.9M USD. This missed the $3.0M USD consensus estimate of the 2 analysts following the company. This was -14.4% below the prior year's 2nd quarter results.

Annual Revenues - ANACOR PHARMACEUTICALS INC (ANAC)

Actuals vs. Estimates for ANACOR PHARMACEUTICALS INC ANAC

Anacor Pharmaceuticals, Inc.'s Annual Revenues

Anacor Pharmaceuticals, Inc. had revenues for the full year 2013 of $17.3M USD. This was 61.0% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ANAC:US $23.29 USD +0.63

ANAC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ANAC.
View Industry Companies
 

Industry Analysis

ANAC

Industry Average

Valuation ANAC Industry Range
Price/Earnings 14.5x
Price/Sales 50.9x
Price/Book 11.6x
Price/Cash Flow 14.3x
TEV/Sales 42.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANACOR PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.